• Published 2 Dec 2025

2nd Innovations in Peptide Science 2026

  • Events

Key topics

Join academic experts, biotech pioneers, and drug development specialists for a one-day event on July 7th, 2026 at BioCity, Nottingham, focused on the next generation of peptide-based therapeutics. This conference will bring together leaders in the peptide community across academia, industry and pharma to explore the latest scientific and clinical dimensions of peptide innovation. We’ll be covering:

  • Novel peptide synthesis platforms and discovery strategies
  • Rational design and therapeutic application of peptides
  • Advanced strategies for peptide cyclisation
  • Peptides in catalysis and biocatalysis
  • Peptide conjugation strategies
  • Methods towards a greener future in peptide synthesis and purification

Featured Speakers

  • Peter Schueltingkemper, Boehringer Ingelheim
  • Thom Sharp, University of Bristol
  • Phil Thompson, Monash University (Australia)
  • Jesmond Dalli, Queen Mary University of London
  • Jody Mason, Revolver Therapeutics & University of Bath
  • Weng Chan, University of Nottingham
  • Pamela Brown, Pam Brown Consulting Ltd

Badge Registration Form

2nd Innovations in Peptide Science 2026

This field is for validation purposes and should be left unchanged.
Name(Required)

This field is hidden when viewing the form

Who Should Attend

This event is designed for professionals involved in the discovery, development, and manufacture of peptide-based therapeutics and complex synthetic medicines.

You should attend if you are:

  • A scientific leader or project head advancing peptide, oligonucleotide, or hybrid modality programs
  • A drug developer working on the integration of peptides with other therapeutic technologies
  • A CSO, VP R&D, or Director of CMC seeking insight into emerging capabilities
  • Heads of Peptide Chemistry, Principal Scientists, and Research Fellows exploring novel synthesis platforms

Join us to explore how scientific innovation in peptides is building the next generation of complex synthetic medicines.

Date, Location and Venue

July 7th 2026

Biocity Nottingham,
Pennyfoot Street,
Nottingham,
Nottinghamshire,
NG1 1GF,
United Kingdom

Nearest Parking

There is no parking available on-site at BioCity so please use the following local car parks:

  • NCP Nottingham Stoney Street
    Stoney St, Nottingham, NG1 1LS
  • Trinity Square Car Park
    North Church Street, Nottingham, NG1 4BT
  • Lace Market Car Park
    33 Pilcher Gate, Nottingham, NG1 1QE

Nearest Airports

  • East Midlands Airport (11.7 miles)
  • Doncaster/ Sheffield – Robin Hood Airport (37.4 miles)
  • Birmingham Airport (47 miles)

Nearest train station

Nottingham (0.5 miles)

Sponsors and Partners

Please contact Dan Croucher (dan.croucher@catsci.com) for sponsorship information.

Highlights from the 1st Innovations in Peptide Science 2025

Attending Organisations at the 1st Innovations in Peptide Science 2025:

Organising Committee

Dan Croucher: dan.croucher@catsci.com

Jordan Fletcher: jordan.fletcher@catsci.com

Stay informed on LinkedIn

Resources & Insights

  • 5 Feb 2026
2nd Advances in Translational Drug Development 2026
  • Events
  • 4 Feb 2026
  • Loïc Roux
Make as Insight, Not Execution – Why “Make” Is the Most Misunderstood Step in DMTA
  • Design-Make-Test
  • DMTA
  • Thought Leaders
  • 22 Jan 2026
  • Loïc Roux
Designing Therapeutic Oligonucleotides – A Practical Framework from Biology to Sequence Selection
  • Design-Make-Test
  • DMTA
  • Oligonucleotides
  • Thought Leaders
  • 15 Jan 2026
  • Jordan Fletcher
Peptide Design in Contemporary DMTA Cycles: How DMTA Drives Translational Refinement
  • Design Make Test Analyse
  • DMTA
  • Peptides
  • Thought Leaders